Clinical management of EGFRI dermatologic toxicities: US perspective.
作者： Mario E. Lacouture , Jonathan Cotliar , Edith P. Mitchell
DOI:
关键词:
摘要: Management of dermatologic toxicities from epidermal growth-factor receptor inhibitors (EGFRIs) is best tailored to the type skin lesions present, extent body surface involvement, and anatomic location affected. Although few randomized trials have been undertaken address treatment skin, hair, or nail side effects this class drugs, some basic principles therapy based on experience referral centers can help mitigate these ensure consistent EGFRI administration maintenance patient quality life. Patient education as expected early physician intervention when appear improve outcomes. Two dermatologists who treat high numbers patients affected by EGFRI-induced cutaneous submit their recommendations for management.
cancernetwork.com参考文章(18)
M.E. Lacouture, S.E. Lai, The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. British Journal of Dermatology. ,vol. 155, pp. 852- 854 ,(2006) , 10.1111/J.1365-2133.2006.07452.X
J.M. Smit, C.G. Bauland, D.S. Wijnberg, P.H.M. Spauwen, Pulsed dye laser treatment, a review of indications and outcome based on published trials. British Journal of Plastic Surgery. ,vol. 58, pp. 981- 987 ,(2005) , 10.1016/J.BJPS.2005.04.057
Mario E. Lacouture, Mechanisms of cutaneous toxicities to EGFR inhibitors. Nature Reviews Cancer. ,vol. 6, pp. 803- 812 ,(2006) , 10.1038/NRC1970
Hsi-Ming Lee, Sebastian G. Ciancio, Gülay Tüter, Maria E. Ryan, Eugene Komaroff, Lorne M. Golub, Subantimicrobial Dose Doxycycline Efficacy as a Matrix Metalloproteinase Inhibitor in Chronic Periodontitis Patients Is Enhanced When Combined With a Non-Steroidal Anti-Inflammatory Drug Journal of Periodontology. ,vol. 75, pp. 453- 463 ,(2004) , 10.1902/JOP.2004.75.3.453
Jill C Fehrenbacher, Charles P Taylor, Michael R Vasko, Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain. ,vol. 105, pp. 133- 141 ,(2003) , 10.1016/S0304-3959(03)00173-8
D. T. Alexandrescu, J. G. Vaillant, C. A. Dasanu, Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors. Clinical and Experimental Dermatology. ,vol. 32, pp. 71- 74 ,(2006) , 10.1111/J.1365-2230.2006.02285.X
R. Gutzmer, T. Werfel, R. Mao, A. Kapp, J. Elsner, Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy. British Journal of Dermatology. ,vol. 153, pp. 849- 851 ,(2005) , 10.1111/J.1365-2133.2005.06835.X
Giampiero Porzio, Federica Aielli, Lucilla Verna, Claudio Porto, Marianna Tudini, Katia Cannita, Corrado Ficorella, Efficacy of pregabalin in the management of cetuximab-related itch. Journal of Pain and Symptom Management. ,vol. 32, pp. 397- 398 ,(2006) , 10.1016/J.JPAINSYMMAN.2006.07.006
Neelam T. Shah, Mark G. Kris, William Pao, Leslie B. Tyson, Barbara M. Pizzo, Murk-Hein Heinemann, Leah Ben-Porat, Dana L. Sachs, Robert T. Heelan, Vincent A. Miller, Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib Journal of Clinical Oncology. ,vol. 23, pp. 165- 174 ,(2005) , 10.1200/JCO.2005.04.057
L.M. Golub, H.-M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, T. Sorsa, Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms Advances in Dental Research. ,vol. 12, pp. 12- 26 ,(1998) , 10.1177/08959374980120010501